Search the Newsreel

Edgewell Personal Care (NYSE:EPC) Tops Q3 EPS Expectations but Revenue Slightly Misses

Edgewell Personal Care (NYSE:EPC) reported mixed Q3 fiscal 2026 results, with adjusted EPS of $0.72 significantly exceeding the $0.62 consensus, while net sales of $570.1 million slightly missed the analyst estimate of $582.2 million. The company's adjusted EBITDA also surpassed expectations, and organic net …

Edgewell Personal Care (EPC) Stock Organic Growth Returns As Interest Strain Persists

Edgewell Personal Care (EPC) saw its stock rise by 2.4% following Q3 2026 earnings, which showed a return to organic net sales growth (up 1.1%). Despite this positive, the company still faces significant challenges, including a 9.1% revenue decline, a 57.7% drop in net …

Personalis (PSNL) Stock Commands A Premium Despite Deepening Losses

Personalis (PSNL) stock maintains a premium valuation despite reporting deepening losses in Q2 2026, with revenue at US$22.36 million and a net loss of US$31.68 million. While the company has achieved milestones like Medicare coverage for its MRD platform and regulatory wins in the …

Edgewell Personal Care (NYSE:EPC) Posts Quarterly Earnings Results, Beats Expectations By $0.11 EPS

Edgewell Personal Care (NYSE:EPC) reported quarterly earnings of $0.72 EPS, surpassing the consensus estimate by $0.11, despite a 9.1% year-over-year decline in revenue. The company maintained its fiscal 2026 adjusted EPS guidance and anticipates stronger fourth-quarter sales and gross-margin expansion. Focus brands are performing …

Edgewell Personal Care Releases Q3 2026 Financial Results

Edgewell Personal Care Company reported adjusted earnings per share of $0.72 for Q3 2026, surpassing Wall Street estimates by 18.0%. While revenue of $570.1M fell slightly short of consensus, it marked a 1.7% increase year-over-year. The company provided full-year 2026 adjusted EPS guidance of …

Edgewell Personal Care (EPC) Looks 15.9% Undervalued on GF Value™

Edgewell Personal Care (NYSE:EPC) Updates FY 2026 Earnings Guidance

Is Edgewell Personal Care Co (EPC) Undervalued After Q3 Earnings

Edgewell Personal Care (EPC) Surpasses Q3 Earnings Estimates

Edgewell Personal Care (EPC) reported Q3 earnings of $0.72 per share, beating the Zacks Consensus Estimate of $0.64 by 12.50%. Despite the earnings beat, the company's revenues of $570.1 million missed the consensus estimate by 1.87% and were lower than the previous year. The …

Edgewell Personal Care (NYSE:EPC) Misses Q2 CY2026 Revenue Estimates

Edgewell Personal Care (NYSE:EPC) reported Q2 CY2026 results, missing Wall Street's revenue expectations with sales up 1.7% year-on-year to $570.1 million, despite an analyst consensus of $577.1 million. However, the company exceeded non-GAAP profit estimates with $0.72 per share, and also beat adjusted EBITDA …

(EPC) Edgewell Personal Care Expects Fiscal 2026 EPS Range $1.80 - $2, vs. FactSet Est of $1.89

Edgewell Personal Care (EPC) has provided its earnings per share (EPS) outlook for fiscal year 2026, expecting a range of $1.80 to $2.00. This forecast is compared against the FactSet consensus estimate of $1.89. The announcement follows the company's fiscal Q3 results, where adjusted …

Edgewell Personal Care Q3 Net Sales Rise to $570.1 Million

Edgewell Personal Care (EPC) reported fiscal third-quarter 2026 net sales of $570.1 million, a 1.7% increase from the prior year, with organic net sales up 1.1%. Despite a decrease in GAAP net earnings, the company maintained its adjusted EPS and EBITDA midpoints for the …

Edgewell Fiscal Q3 2026 Earnings: Organic Sales Return to Growth but Margins Contract

Edgewell Personal Care (NYSE: EPC) reported a 1.7% increase in net sales to $570.1 million for fiscal Q3 2026, with organic net sales growing 1.1%, primarily due to North American performance. However, GAAP diluted EPS fell significantly to $0.26 from $0.46, and margins contracted …

Edgewell Personal Care beats earnings but misses on revenue

Edgewell Personal Care (NYSE:EPC) reported its third-quarter fiscal 2026 results, exceeding earnings expectations with an adjusted EPS of $0.72 against a consensus of $0.63. However, the company missed revenue estimates, reporting $570.1 million compared to an anticipated $578.09 million. Despite the revenue miss, organic …

Earnings Flash (EPC) Edgewell Personal Care Company Posts Q3 Adjusted EPS $0.72 per Share

Edgewell Personal Care Company (EPC) reported its Q3 adjusted EPS at $0.72 per share. The company also reported Q3 revenue of $570.1 million and updated its earnings guidance for the fiscal year 2026, expecting an EPS range of $1.80 - $2.00. Additionally, Edgewell declared …

Edgewell Personal Care Announces Third Quarter Fiscal 2026 Results

Organic Net Sales Returned to Growth; North America Performance Improved Meaningfully Adjusted EPS and Adjusted EBITDA Exceeded Expectations Full Year Outlook Narrowed; Mid-points for Adjusted EPS and Adjusted EBITDA Remain Unchanged SHELTON, Conn., Aug. 5, 2026 /PRNewswire/ -- Edgewell Personal Care Company (NYSE: EPC) …

Personalis (NASDAQ: PSNL) posts larger loss and strikes Tempus cash-stock merger

Personalis, a cancer genomics testing company, reported a wider loss in Q2 2026 despite increased revenue, driven by higher operating expenses. The company announced it has entered into a merger agreement to be acquired by Tempus AI, Inc. in a cash-stock deal. The merger …

Edgewell Personal Care Company (NYSE: EPC) sells Feminine Care unit and posts $62.6M loss

Edgewell North America Sales Rise 3% as Organic Growth Returns

Personalis Reports Second Quarter 2026 Results and Recent Highlights

Personalis, Inc. reported strong financial results for the second quarter of 2026, with revenue growing 30% year-over-year to $22.4 million and clinical test volume surging 199%. Key achievements include securing Medicare coverage for its NeXT Personal® test for immunotherapy monitoring and neoadjuvant breast cancer …

Personalis (NASDAQ:PSNL) Announces Quarterly Earnings Results, Misses Expectations By $0.05 EPS

Earnings Flash (PSNL) Personalis, Inc. Reports Q2 Revenue $22.4M, vs. FactSet Est of $16.7M

Personalis, Inc. (PSNL) announced its Q2 revenue of $22.4 million, significantly exceeding FactSet's estimated $16.7 million. The company, which specializes in advanced cancer genomic tests and analytics, focuses on supporting personalized cancer vaccines and immunotherapies. This earnings beat follows recent news including Tempus AI's …

Personalis (NASDAQ: PSNL) Q2 revenue jumps 30% as clinical tests surge

Personalis, Inc. reported a 30% increase in Q2 2026 revenue to $22.4 million, driven by a 199% surge in clinical test volume and strong pharma testing services. Despite the revenue growth, the company posted a net loss of $31.7 million. Following a merger agreement …

PSNL Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Proposed Sale of Personalis to Tempus AI

The Monsey law firm of Wohl & Fruchter LLP is investigating the fairness of the proposed sale of Personalis, Inc. (Nasdaq: PSNL) to Tempus AI, Inc. for $16.25 per share. The investigation comes after Tempus shares fell post-announcement, leading to a decrease in Personalis's …

Edgewell earnings up next: Can sun care offset shaving pressure? By Investing.com

Edgewell Personal Care Co. is preparing to release its fiscal third-quarter results, with analysts anticipating earnings of $0.63 per share on $576.6 million in revenue. The company's strategy post-divestiture of its feminine care unit will be under scrutiny, particularly the performance of its sun …

International Personal Finance (IPF) Scheme Effective as £2.50 Per Share Cash Deal Finalizes

Personalis: Q2 Earnings Snapshot

Personalis (PSNL) Reports Q2 Loss, Tops Revenue Estimates

Edgewell Personal Care Earnings: What To Look For From EPC

Edgewell Personal Care (NYSE: EPC) is set to announce its earnings results this Wednesday. The company met revenue expectations last quarter and saw strong beats on EBITDA and organic revenue estimates. Analysts expect a 3% year-on-year revenue growth this quarter, a reversal from the …

Edgewell Personal Care Company $EPC Stock Position Decreased by Dimensional Fund Advisors LP

Dimensional Fund Advisors LP reduced its stake in Edgewell Personal Care Company (NYSE:EPC) by 6.7% in the first quarter, selling 174,214 shares but still holding 5.22% of the company. Other institutional investors also adjusted their positions, and the company has a "Hold" rating from …

Resona Holdings (TSE:8308) Lifts Guidance And Launches Buyback, Is The Stock Too Pricey?

Resona Holdings (TSE:8308) Stock Sees Profit Strength But Revenue Mix Questions Persist

Sonata Software announces Q1FY27 results date; earnings call set for Aug 7

Edgewell Personal Care Company (NYSE:EPC) Given Consensus Recommendation of "Hold" by Brokerages

Edgewell Personal Care Company (NYSE:EPC) has received a consensus "Hold" recommendation from brokerages, with an average 12-month target price of $28.00. The company recently reported quarterly earnings of $0.60 per share, surpassing analyst expectations, and pays a quarterly dividend of $0.15 per share. Institutional …

How Investors May Respond To Tempus AI (TEM) Q2 Profit Return, Outlook Hike, Personalis Deal

Tempus AI (TEM) reported a profitable Q2 2026, swinging from a net loss to a net income of US$5.64 million, with revenue of US$382.49 million, and subsequently raised its full-year 2026 revenue outlook. The company also announced the acquisition of Personalis, enhancing its oncology …

Resona Holdings, Inc. 2027 Q1 - Results - Earnings Call Presentation (OTCMKTS:RSHGY) 2026-08-01